• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺功能减退肥胖患者左甲状腺素替代治疗的合适剂量

Appropriate dose of levothyroxine replacement therapy for hypothyroid obese patients.

作者信息

Ratanapornsompong Ganista, Sriphrapradang Chutintorn

机构信息

Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand.

出版信息

J Clin Transl Endocrinol. 2021 Jul 30;25:100264. doi: 10.1016/j.jcte.2021.100264. eCollection 2021 Sep.

DOI:10.1016/j.jcte.2021.100264
PMID:34401353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8350177/
Abstract

BACKGROUND

Athyreotic patients require a daily levothyroxine (LT4) doses of 1.6-1.8 mcg/kg of actual body weight (BW) to achieve normal thyroid stimulating hormone (TSH) levels. Lean body mass (LBM) calculation may be a more accurate determination of LT4 dose in obese patients. Previous studies were mainly investigated in Caucasians and LBM is markedly different between various ethnic groups. We aim to identify the optimal dose of LT4 replacement therapy in hypothyroid Thai patients including obese subjects.

METHODS

We retrospectively reviewed the medical records of Thai adults with hypothyroidism at the thyroid clinic. Patients had been received LT4 (Brand: Euthyrox) at a stable dose ≥ 75 mcg/day for at least 1 year. Patients with thyroid cancer, pregnant, and lactating women were excluded. LBM was calculated by the Hume formula.

RESULTS

Two hundred patients (80% females) with a mean age of 48.6 ± 14.8 years and a body mass index (BMI) of 24.5 ± 4.6 kg/m were included. Daily LT4 dose/kg of actual BW according to BMI 18.5-24.9, 25-29.9, and ≥ 30 kg/m were 1.67 ± 0.27, 1.51 ± 0.28 and 1.39 ± 0.34 mcg/kg, respectively. In contrast, LT4 dose/kg of LBM were 2.31 ± 0.39, 2.35 ± 0.45 and 2.36 ± 0.51 mcg/kg, respectively.

CONCLUSIONS

LBM is considered a better indicator for calculating an appropriate LT4 replacement dose than actual BW in hypothyroid obese Thai patients. The recommended daily dose of LT4 is 2.3 mcg/kg of LBM that could be applied for all ranges of BMI.

摘要

背景

甲状腺功能减退患者需要每日服用1.6 - 1.8微克/千克实际体重(BW)的左甲状腺素(LT4),以达到正常的促甲状腺激素(TSH)水平。瘦体重(LBM)计算可能是确定肥胖患者LT4剂量的更准确方法。以往研究主要针对高加索人,且不同种族间的LBM存在显著差异。我们旨在确定甲状腺功能减退的泰国患者(包括肥胖患者)LT4替代治疗的最佳剂量。

方法

我们回顾性分析了甲状腺门诊泰国成年甲状腺功能减退患者的病历。患者接受稳定剂量≥75微克/天的LT4(品牌:优甲乐)治疗至少1年。排除甲状腺癌患者、孕妇和哺乳期妇女。LBM通过休谟公式计算。

结果

纳入200例患者(80%为女性),平均年龄48.6±14.8岁,体重指数(BMI)为24.5±4.6千克/平方米。根据BMI 18.5 - 24.9、25 - 29.9和≥30千克/平方米,每日LT4剂量/千克实际体重分别为1.67±0.27、1.51±0.28和1.39±0.34微克/千克。相比之下,每日LT4剂量/千克LBM分别为2.31±0.39、2.35±0.45和2.36±0.51微克/千克。

结论

对于甲状腺功能减退的肥胖泰国患者,LBM被认为是比实际体重更好的计算合适LT4替代剂量的指标。LT4的推荐日剂量为2.3微克/千克LBM,可应用于所有BMI范围。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb10/8350177/6a1d6d4a6a33/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb10/8350177/6a1d6d4a6a33/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb10/8350177/6a1d6d4a6a33/gr1.jpg

相似文献

1
Appropriate dose of levothyroxine replacement therapy for hypothyroid obese patients.甲状腺功能减退肥胖患者左甲状腺素替代治疗的合适剂量
J Clin Transl Endocrinol. 2021 Jul 30;25:100264. doi: 10.1016/j.jcte.2021.100264. eCollection 2021 Sep.
2
Profile of Levothyroxine Replacement Therapy in Graves' Disease Patients with Hypothyroidism Post-Radioactive Iodine Ablation: Focus on Different Weight-Based Regimens.放射性碘消融术后甲状腺功能减退的格雷夫斯病患者左甲状腺素替代治疗概况:关注不同体重为基础的治疗方案。
J ASEAN Fed Endocr Soc. 2022;37(1):62-68. doi: 10.15605/jafes.037.01.19. Epub 2022 May 7.
3
Comparison of the Efficacy of Levothyroxine Suppression Dose Computed Based on Actual Body Weight vs. Lean Body Mass among Differentiated Thyroid Cancer Patients: A Randomized Controlled Trial.分化型甲状腺癌患者中基于实际体重与瘦体重计算的左甲状腺素抑制剂量疗效比较:一项随机对照试验
J ASEAN Fed Endocr Soc. 2019;34(2):158-163. doi: 10.15605/jafes.034.02.06. Epub 2019 Nov 10.
4
LEVOTHYROXINE REPLACEMENT IN OBESE HYPOTHYROID FEMALES AFTER TOTAL THYROIDECTOMY.全甲状腺切除术后肥胖甲状腺功能减退女性的左甲状腺素替代治疗
Endocr Pract. 2016 Jan;22(1):22-9. doi: 10.4158/EP15836.OR. Epub 2015 Oct 5.
5
Weight Loss and Variation of Levothyroxine Requirements in Hypothyroid Obese Patients After Bariatric Surgery.减重手术后甲状腺功能减退肥胖患者的体重减轻及左甲状腺素需求量的变化
Thyroid. 2016 Apr;26(4):499-503. doi: 10.1089/thy.2015.0473. Epub 2016 Mar 16.
6
Evaluation of Thyroid Hormone Replacement Dosing in Morbidly Obese Hypothyroid Patients after Bariatric Surgery-Induced Weight Loss.减重手术后体重减轻的病态肥胖甲状腺功能减退患者甲状腺激素替代剂量的评估
J Clin Med. 2021 Aug 19;10(16):3685. doi: 10.3390/jcm10163685.
7
Evaluation of Thyroid Hormone Replacement Dosing in Overweight and Obese Patients After a Thyroidectomy.甲状腺切除术后超重和肥胖患者甲状腺激素替代剂量的评估。
Thyroid. 2019 Nov;29(11):1558-1562. doi: 10.1089/thy.2019.0251. Epub 2019 Oct 1.
8
Out-of-Reference Range Thyroid-Stimulating Hormone Levels in Levothyroxine-Treated Primary Hypothyroid Patients: A Multicenter Observational Study.左甲状腺素治疗的原发性甲状腺功能减退患者促甲状腺激素水平超出参考范围:一项多中心观察性研究
Front Endocrinol (Lausanne). 2017 Sep 12;8:215. doi: 10.3389/fendo.2017.00215. eCollection 2017.
9
Management of overt and subclinical hypothyroidism. Factors influencing L-thyroxine dosage.显性和亚临床甲状腺功能减退的管理。影响左甲状腺素剂量的因素。
Medicina (B Aires). 1999;59(6):698-704.
10
Lean body mass-based levothyroxine replacement in young athyrotic patients with differentiated carcinoma of thyroid.基于去脂体重的左甲状腺素替代治疗年轻甲状腺功能减退且患有分化型甲状腺癌的患者
Indian J Endocrinol Metab. 2013 Mar;17(2):254-9. doi: 10.4103/2230-8210.109697.

引用本文的文献

1
Semaglutide therapy and iatrogenic thyrotoxicosis.司美格鲁肽治疗与医源性甲状腺毒症
Endocrinol Diabetes Metab Case Rep. 2025 Jul 10;2025(3). doi: 10.1530/EDM-25-0065. Print 2025 Jul 1.
2
Macro-Thyrotropin Syndrome: Prevalence and Clinical Profile of an Under-Recognised Rare Entity in Thyroidology.巨促甲状腺素综合征:甲状腺学中一种未被充分认识的罕见病症的患病率及临床特征
Indian J Endocrinol Metab. 2025 Jan-Feb;29(1):95-100. doi: 10.4103/ijem.ijem_256_24. Epub 2025 Feb 28.
3
Triiodothyronine/Thyroxine Ratio as a Marker of Clinical Response to Levothyroxine Replacement in Patients With Hypothyroidism.

本文引用的文献

1
Evaluation of Thyroid Hormone Replacement Dosing in Overweight and Obese Patients After a Thyroidectomy.甲状腺切除术后超重和肥胖患者甲状腺激素替代剂量的评估。
Thyroid. 2019 Nov;29(11):1558-1562. doi: 10.1089/thy.2019.0251. Epub 2019 Oct 1.
2
Relationship between Helicobacter pylori infection and obesity in Chinese adults: A systematic review with meta-analysis.中国成年人幽门螺杆菌感染与肥胖的关系:系统评价和荟萃分析。
PLoS One. 2019 Sep 11;14(9):e0221076. doi: 10.1371/journal.pone.0221076. eCollection 2019.
3
Thyroid hormone therapy for hypothyroidism.
三碘甲状腺原氨酸/甲状腺素比值作为甲状腺功能减退患者左甲状腺素替代治疗临床反应的标志物
Cureus. 2024 Apr 16;16(4):e58370. doi: 10.7759/cureus.58370. eCollection 2024 Apr.
4
A Clinical Audit of Thyroid Hormonal Replacement After Total Thyroidectomy.全甲状腺切除术后甲状腺激素替代治疗的临床审计
Cureus. 2023 Dec 12;15(12):e50374. doi: 10.7759/cureus.50374. eCollection 2023 Dec.
5
Levothyroxine therapy, calculated deiodinases activity and basal metabolic rate in obese or nonobese patients after total thyroidectomy for differentiated thyroid cancer, results of a retrospective observational study.左旋甲状腺素治疗、计算脱碘酶活性和基础代谢率在分化型甲状腺癌全甲状腺切除术后肥胖或非肥胖患者中的作用:一项回顾性观察研究的结果。
Endocrinol Diabetes Metab. 2023 Mar;6(2):e406. doi: 10.1002/edm2.406. Epub 2023 Feb 1.
6
Profile of Levothyroxine Replacement Therapy in Graves' Disease Patients with Hypothyroidism Post-Radioactive Iodine Ablation: Focus on Different Weight-Based Regimens.放射性碘消融术后甲状腺功能减退的格雷夫斯病患者左甲状腺素替代治疗概况:关注不同体重为基础的治疗方案。
J ASEAN Fed Endocr Soc. 2022;37(1):62-68. doi: 10.15605/jafes.037.01.19. Epub 2022 May 7.
甲状腺激素治疗甲状腺功能减退症。
Endocrine. 2019 Oct;66(1):18-26. doi: 10.1007/s12020-019-02023-7. Epub 2019 Aug 1.
4
Optimal levothyroxine dose in post-total thyroidectomy patients: a prediction model for initial dose titration.全甲状腺切除术后患者的最佳左甲状腺素剂量:初始剂量滴定的预测模型。
Eur Arch Otorhinolaryngol. 2019 Sep;276(9):2559-2564. doi: 10.1007/s00405-019-05523-4. Epub 2019 Jun 27.
5
Primary hypothyroidism in the community: Lower daily dosages of levothyroxine replacement therapy for Asian patients.社区中的原发性甲状腺功能减退症:亚洲患者左甲状腺素替代治疗的每日剂量较低。
Medicine (Baltimore). 2017 Feb;96(7):e6145. doi: 10.1097/MD.0000000000006145.
6
The classic pathways of thyroid hormone metabolism.甲状腺激素代谢的经典途径。
Mol Cell Endocrinol. 2017 Dec 15;458:29-38. doi: 10.1016/j.mce.2017.01.025. Epub 2017 Jan 18.
7
Weight Loss and Variation of Levothyroxine Requirements in Hypothyroid Obese Patients After Bariatric Surgery.减重手术后甲状腺功能减退肥胖患者的体重减轻及左甲状腺素需求量的变化
Thyroid. 2016 Apr;26(4):499-503. doi: 10.1089/thy.2015.0473. Epub 2016 Mar 16.
8
Prospective Intervention of a Novel Levothyroxine Dosing Protocol Based on Body Mass Index after Thyroidectomy.甲状腺切除术后基于体重指数的新型左甲状腺素给药方案的前瞻性干预
J Am Coll Surg. 2016 Jan;222(1):83-8. doi: 10.1016/j.jamcollsurg.2015.10.005. Epub 2015 Oct 21.
9
Less favorable body composition and adipokines in South Asians compared with other US ethnic groups: results from the MASALA and MESA studies.与其他美国种族群体相比,南亚人的身体成分和脂肪因子情况较差:来自MASALA和MESA研究的结果。
Int J Obes (Lond). 2016 Apr;40(4):639-45. doi: 10.1038/ijo.2015.219. Epub 2015 Dec 8.
10
LEVOTHYROXINE REPLACEMENT IN OBESE HYPOTHYROID FEMALES AFTER TOTAL THYROIDECTOMY.全甲状腺切除术后肥胖甲状腺功能减退女性的左甲状腺素替代治疗
Endocr Pract. 2016 Jan;22(1):22-9. doi: 10.4158/EP15836.OR. Epub 2015 Oct 5.